Suchergebnisse

Presents a new product implementation model which is designed to
reduce the risk inherent in new product ventures in the industrial
marketplace. Show that while there is debate over the number of
failures, there is little debate that the new product failure rate is
high. Describes a process that gives the industrial firm the ability to
exert greater control over internal and external factors critical to the
successful new product implementation. Concludes that the model is
appropriate for many types of firms.

This paper describes a not-for-profit healthcare providers strategy to provide its economically disadvantaged patients with access to low cost pharmaceuticals. Initially, an in-house pharmacy was established, supported by a satellite distribution system using a telepharmacy solution to extend medications to its patients at remote sites. New federal legislation which provided access to low cost insurance through Medicare Part D to many of the providers disadvantaged patients, along with state licensing requirements forced the healthcare provider to reassess the economics of its pharmaceutical distribution system and seek other alternatives. Among the alternatives the healthcare provider considered was partnering with for-profit pharmaceutical companies in order to reach their patients.